{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:10:13Z","timestamp":1792131013185,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016676","name":"Tom Sherak MS Hope Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cct.2023.107333","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T11:43:20Z","timestamp":1695210200000},"page":"107333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis"],"prefix":"10.1016","volume":"134","author":[{"given":"Alyssa","family":"Nylander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Rowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann A.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia R.","family":"Mayoral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Pease-Raissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Bove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cct.2023.107333_bb0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3111\/13696998.2013.778268","article-title":"The cost burden of multiple sclerosis in the United States: a systematic review of the literature","volume":"16","author":"Adelman","year":"2013","journal-title":"J. Med. Econ."},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J. Neurol."},{"issue":"10111","key":"10.1016\/j.cct.2023.107333_bb0015","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet."},{"issue":"20","key":"10.1016\/j.cct.2023.107333_bb0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial","volume":"120","author":"Caverzasi","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.cct.2023.107333_bb0025","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.cct.2023.107333_bb0030","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1523\/JNEUROSCI.1530-18.2019","article-title":"Selective estrogen receptor modulators enhance CNS remyelination independent of estrogen receptors","volume":"39","author":"Rankin","year":"2019","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.cct.2023.107333_bb0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.cct.2023.107333_bb0040","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.cct.2023.107333_bb0045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/jbmr.252","article-title":"Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis","volume":"26","author":"Itabashi","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.cct.2023.107333_bb0050","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.cct.2023.107333_bb0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstet. Gynecol."},{"issue":"10","key":"10.1016\/j.cct.2023.107333_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States: A population-based estimate using health claims data","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0075","article-title":"Application of an adaptive, digital, game-based approach for cognitive assessment in multiple sclerosis: observational study","volume":"23","author":"Hsu","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41598-018-35734-4","article-title":"Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis","volume":"9","author":"Hooijmans","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10735-020-09929-x","article-title":"Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis","volume":"52","author":"Khalilian","year":"2021","journal-title":"J. Mol. Histol."},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/brain\/awaa381","article-title":"Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis","volume":"144","author":"Schiavi","year":"2021","journal-title":"Brain."},{"issue":"3","key":"10.1016\/j.cct.2023.107333_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/13524585221143726","article-title":"Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis","volume":"29","author":"Block","year":"2023","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.cct.2023.107333_bb0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00415-016-8334-6","article-title":"Continuous daily assessment of multiple sclerosis disability using remote step count monitoring","volume":"264","author":"Block","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.cct.2023.107333_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.860008","article-title":"Making every step count: minute-by-minute characterization of step counts augments remote activity monitoring in people with multiple sclerosis","volume":"13","author":"Block","year":"2022","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.cct.2023.107333_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.cct.2023.107333_bb0115","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials","volume":"4","author":"Schulz","year":"2010","journal-title":"Open Med."},{"issue":"8","key":"10.1016\/j.cct.2023.107333_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235615","article-title":"Imaging correlates of visual function in multiple sclerosis","volume":"15","author":"Caverzasi","year":"2020","journal-title":"PLoS One"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714423002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:01:16Z","timestamp":1761555676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714423002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":22,"alternative-id":["S1551714423002562"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2023.107333","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-WRAP (Remyelination for women at risk of axonal loss and progression): A phase II randomized placebo-controlled delayed-start trial of bazedoxifene for myelin repair in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2023.107333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107333"}}